DEF: Sadot Group Seeks Shareholder Nod for Equity, Debt, Governance

Sadot Group Inc. is seeking shareholder approval for a substantial increase in authorized common stock, new equity incentive plans, and the conversion of significant convertible debt, alongside director elections and auditor ratification.

Summary

• The 2024 Annual Meeting of Stockholders will be held virtually on April 13, 2026, at 10:00 a.m., Central Time.
• Shareholders will vote on the election of five directors, the ratification of Kreit & Chiu CPA LLP as the independent registered public accounting firm for 2025, and the approval of the 2025 Equity Incentive Plan.
• A key proposal is to amend the Company's articles of incorporation to increase the number of authorized shares of common stock from 2,000,000 to 250,000,000.
• Approval is sought for the issuance of shares of common stock to Helena Global Investment Opportunities I Ltd. for up to $10,000,000 under a Purchase Agreement, with shares priced at 97% of the lowest daily closing VWAP during the pricing period.
• Shareholder approval is also requested for the issuance of common stock to Target Capital 12, LLC and Secure Net Capital (December 2024 Purchasers) upon conversion of $3.75 million principal amount of convertible senior notes. The conversion price was amended from $4.10 to $1.00, and then to 97% of the lowest closing price during the three trading days prior to conversion.
• Approval is sought for the issuance of common stock to Target Capital 1, LLC (October 2024 Purchaser) upon conversion of a $1.375 million principal amount convertible promissory note. The conversion price was amended from the greater of $0.2366 or 80% market price to $1.00, and then to 97% of the lowest closing price during the three trading days prior to conversion.
• The Company seeks approval for the issuance of 793,000 shares of common stock to Aggia LLC FZ as part of a settlement agreement dated November 20, 2025, which also included an initial issuance of 257,000 shares and a $75,000 cash payment, terminating prior service agreements.
• A 1-for-10 reverse stock split became effective on September 15, 2025, with common stock trading on the Nasdaq Capital Market on a post-split basis.
• As of February 17, 2026, there were 1,849,080 common shares and 10,000 shares of Series A Preferred Stock outstanding, with each Series A Preferred share carrying 14.5244 votes for an aggregate of 145,244 votes.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with caution due to the substantial potential for dilution from the proposed increase in authorized shares and the terms of the convertible debt conversions, which appear unfavorable to existing shareholders. While capital raises are positive for liquidity, the associated dilution and executive turnover present significant concerns.

Positives

• Seeking shareholder approval for capital raises and equity plans demonstrates adherence to corporate governance and Nasdaq rules.
• The 2025 Equity Incentive Plan aims to attract and retain key personnel, aligning their interests with stockholders through equity awards.
• The Purchase Agreement with Helena provides a potential source of up to $10,000,000 in capital for working capital and general corporate purposes.
• The conversion of convertible notes (December 2024 and October 2024) into equity, rather than cash repayment, helps preserve the Company's cash reserves.
• The Settlement Agreement with Aggia LLC FZ resolves prior claims and obligations, terminating service agreements and related promissory notes, which could avoid costly litigation.

Negatives

• The proposed increase in authorized common stock from 2,000,000 to 250,000,000 shares (a 125x increase) creates significant potential for future dilution of existing shareholders.
• The 2025 Equity Incentive Plan authorizes an additional 7,000,000 common shares for awards, further contributing to potential dilution.
• Conversion prices for the December 2024 and October 2024 notes were significantly reduced (e.g., from $4.10 to $1.00, then to 97% of lowest closing price), indicating potentially unfavorable terms for existing shareholders.
• The Company faces potential penalties for failing to meet deadlines for filing or declaring effective registration statements related to the Helena agreement and December 2024 notes.
• There has been significant executive turnover, with Michael J. Roper (former CEO/Chief Governance and Compliance Officer), Jennifer Black (former CFO), Paul Sansom (CFO), and Aimee Infante (CMO) all departing in late 2025 or early 2026.
• A substantial severance payment of $734,000 (or $550,500 with a 25% discount) is due to Michael Roper.
• A related party loan from September 2024 of $0.6 million with a $0.1 million discount had its maturity extended multiple times, indicating ongoing financial arrangements with related parties.
• A 30% non-controlling interest in Sadot South Korea is 50% owned by a former board member who also receives compensation, raising potential conflict of interest concerns.

Risks

• The proposed increase in authorized common stock to 250,000,000 shares and the issuance of shares for various agreements (Helena, convertible notes, Aggia settlement, equity incentive plan) could significantly dilute existing shareholders' interests in earnings per share, voting power, liquidation value, and book/market value per share.
• An increase in the authorized number of shares of common stock could be used to delay or prevent a change in control of the Company, potentially entrenching current management.
• Failure to obtain shareholder approval for certain share issuances (e.g., Helena, convertible notes, Aggia) could lead to non-compliance with Nasdaq Listing Rules 5635(b) and 5635(d), potentially impacting the Company's Nasdaq listing.
• Failure to meet deadlines for filing or effectiveness of registration statements (e.g., for Helena and December 2024 notes) could result in significant liquidated damages and other remedies for the investors.
• Hedging activities by investors like Helena could negatively impact the market price of the Company's publicly-traded securities.
• The disclosure that the Borrower's ability to continue as a going concern is not an admission of inability to pay debts highlights potential financial instability.

Future Outlook

The Company intends to use the net proceeds from any sales of common stock pursuant to the Helena Purchase Agreement for working capital and general corporate purposes. The proposed increase in authorized shares and the 2025 Equity Incentive Plan are designed to provide flexibility for future equity financings, acquisitions, strategic business alliances, and employee incentives. The Company will continue to seek shareholder approval for the issuance of Subsequent Shares to Aggia if not obtained by March 31, 2026.

Management Comments

• "Your vote is important to us. Please act as soon as possible to vote your shares."
• "We encourage you to vote by proxy so that your shares will be represented and voted at the meeting, whether or not you can attend."
• "We look forward to seeing you at the annual meeting."
• "The Board believes that an increase in the number of authorized shares of common stock is desirable. The increase will provide the Company with the flexibility to issue shares of common stock in connection with possible future stock dividends or stock splits, equity financings, opportunities for expanding our business through investments, acquisitions or strategic business alliances, management incentive and employee benefit plans and for other general corporate purposes, while avoiding the additional expense and delay of calling a special shareholders meeting to authorize the issuance of stock."
• "Our Board of Directors has determined that the Purchase Agreement... is in the best interests of us and our stockholders because the right to sell the shares of common stock to Helena provides us with a reliable source of capital for working capital and general corporate purposes."
• "Our Board of Directors has determined that allowing for the conversion of the December 2024 Notes... is in the best interests of us and our stockholders as it will allow the Company to use its cash reserves, if any, for working capital and general corporate purposes."
• "Our Board of Directors has determined that allowing for the conversion of the October 2024 Note... is in the best interests of us and our stockholders as it will allow the Company to use its cash reserves, if any, for working capital and general corporate purposes."
• "Our Board of Directors has determined that allowing for the issuance of the Subsequent Shares [to Aggia]... is in the best interests of us and our stockholders as it will allow the Company to use its cash reserves, if any, for working capital and general corporate purposes."

Industry Context

StockSavvy.ai notes that the significant proposed increase in authorized shares and the conversion of convertible debt at discounted prices are common strategies for growth-oriented companies seeking to raise capital and manage debt, particularly those in earlier stages or facing liquidity challenges. However, such actions often come at the cost of substantial shareholder dilution, which can be a significant concern for investors. The high executive turnover also suggests potential instability, which is atypical for established industry leaders.

Management Changes

Corporate Governance

Legal Proceedings

• The Settlement Agreement and Mutual Release with Aggia LLC FZ was entered into on November 20, 2025, to fully settle, compromise, and discharge all claims, debts, obligations, and liabilities arising out of or related to prior service agreements, thereby avoiding potentially costly litigation.

Related Party Transactions

• Issuance of 313 common shares to board members as compensation during Q4 2022 (January 5, 2023).
• Issuance of options to purchase an aggregate of 5,310 shares and 689 shares of common stock to executive team members on February 27, 2023, and March 15, 2023, respectively.
• Issuance of 28,488 shares of common stock to a consultant for services rendered (March 27, 2023).
• Issuance of 297 common shares to board members as compensation during Q1 2023 (April 5, 2023).
• Issuance of 1,396 shares of common stock to a consultant for services rendered (May 10, 2023).
• Issuance of 27,200 shares of common stock to a consultant for services rendered (May 25, 2023).
• Vesting of 8,547 shares of common stock to a consultant for services rendered (June 30, 2023).
• Issuance of 328 common shares to board members as compensation during Q2 2023 (July 11, 2023).
• Issuance of 88,554 Restricted Share Awards (effective April 1, 2023).
• Issuance of 500 shares of common stock to a consultant for services rendered (August 15, 2023).
• Issuance of 2,272 shares of common stock in fees to a consultant related to the SEPA (September 25, 2023).
• Vesting of 5,383 shares of common stock to a consultant for services rendered (September 30, 2023).
• Issuance of 636 common shares to board members as compensation during Q3 2023 (October 2, 2023).
• Issuance of 855 shares of common stock to consultants for services rendered (October 20, 2023).
• Issuance of 804, 1,591, 2,373, 2,713, and 2,679 shares of common stock in connection with the conversion of note payables (November-December 2023).
• Issuance of 20,226 RSAs to certain members of the board of directors, consultants, and employees (December 19, 2023).
• Vesting of 20,986 shares of common stock to Aggia LLC FZ as consulting fees earned during Q4 2023 (December 31, 2023).
• Issuance of 10,559 common shares to board members as compensation earned during Q4 2023 (January 4, 2024).
• Aggia LLC FZ, which owned 9.2% of the Company's common stock as of June 30, 2025, recorded stock-based consulting expenses of $1.0 million for the six months ended June 30, 2025, and $2.4 million for the six months ended June 30, 2024. The Company also reimbursed Aggia for operating costs of $1.5 million and $2.1 million for the same periods, respectively.
• A Settlement Agreement and Mutual Release was entered into with Aggia LLC FZ on November 20, 2025, for the issuance of 1,050,000 shares of common stock and a $75,000 cash payment, terminating prior service agreements and related promissory notes.
• A loan from a related party of $0.6 million, with a $0.1 million discount, was received on September 19, 2024, and its maturity was extended to December 31, 2025.
• Sadot South Korea, launched on March 26, 2025, has a 30% non-controlling interest that is 50% owned by a former board member who also receives compensation for services. 55,886 shares of stock were issued to this board member as compensation from January 6, 2025, through June 30, 2025.
• The Company has entered into indemnification agreements with each of its directors and certain executive officers.

Stakeholder Impact

• **Shareholders**: Face significant potential for dilution due to the proposed 125x increase in authorized shares, the new equity incentive plan, and the conversion of convertible notes at potentially unfavorable prices. Their voting power and economic interest could be substantially reduced.
• **Employees/Management**: The 2025 Equity Incentive Plan provides a mechanism to attract and retain key personnel through equity awards, potentially aligning their interests with the Company's long-term performance. However, recent high executive turnover may indicate internal instability.
• **Creditors (Convertible Note Holders)**: The conversion of their notes into equity allows them to become shareholders, potentially at a discounted rate, and avoids cash repayment, which could be beneficial for them if the Company's cash reserves are limited.
• **Aggia LLC FZ**: Benefits from the settlement agreement, receiving a substantial number of shares and cash, which resolves prior disputes and terminates ongoing obligations, providing a clear resolution to their relationship with the Company.

Next Steps

• Hold the 2024 Annual Meeting of Stockholders virtually on April 13, 2026.
• Shareholders will vote on the election of directors, ratification of the independent auditor, approval of the increase in authorized common stock, approval of the 2025 Equity Incentive Plan, and approval of various share issuances.
• The Company will file necessary proxy materials and disclosures to seek shareholder approval for the issuance of the 793,000 Subsequent Shares to Aggia LLC FZ.
• The Company will use commercially reasonable efforts to obtain shareholder approval for the Aggia Subsequent Shares at its next annual or special meeting.
• The Company will file a Current Report on Form 8-K with the final voting results within four business days after the Annual Meeting.

Key Dates

Recommendation

The filing reveals multiple red flags for investors, including a massive proposed increase in authorized shares (125x), significant dilution from convertible debt conversions at heavily discounted prices, and high executive turnover. While the company is addressing capital needs and settling disputes, the terms appear highly unfavorable to existing shareholders and suggest underlying financial distress. The potential for further dilution and the instability in management warrant a cautious to negative outlook, making a 'sell' recommendation appropriate for risk-averse investors.

Keywords

Sadot Group, SDOT, Proxy Statement, Shareholder Meeting, Authorized Shares, Equity Incentive Plan, Convertible Notes, Debt Conversion, Dilution, Nasdaq Listing Rules, Corporate Governance, Related Party Transactions, Executive Compensation, Reverse Stock Split, Capital Raise